UK markets close in 5 hours 4 minutes

Kiromic BioPharma, Inc. (KRBP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.3820-0.0180 (-4.50%)
At close: 04:00PM EDT
0.3825 +0.00 (+0.13%)
Pre-market: 04:32AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 6.30M
Enterprise value -6.31M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.31
Enterprise value/revenue N/A
Enterprise value/EBITDA 0.22

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-91.12%
S&P500 52-week change 3-11.01%
52-week high 34.6000
52-week low 30.2300
50-day moving average 30.4350
200-day moving average 31.3552

Share statistics

Avg vol (3-month) 31.08M
Avg vol (10-day) 3150.05k
Shares outstanding 515.67M
Implied shares outstanding 6N/A
Float 811.18M
% held by insiders 112.66%
% held by institutions 112.98%
Shares short (14 Jun 2022) 4519.9k
Short ratio (14 Jun 2022) 40.21
Short % of float (14 Jun 2022) 43.43%
Short % of shares outstanding (14 Jun 2022) 43.32%
Shares short (prior month 12 May 2022) 455.67k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-99.58%
Return on equity (ttm)-204.33%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -28.16M
Net income avi to common (ttm)-29.38M
Diluted EPS (ttm)-2.1820
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)15.12M
Total cash per share (mrq)0.96
Total debt (mrq)2.51M
Total debt/equity (mrq)12.55
Current ratio (mrq)4.08
Book value per share (mrq)1.28

Cash flow statement

Operating cash flow (ttm)-25.26M
Levered free cash flow (ttm)-18.06M